Bilateral occlusive retinal vasculitis in a patient with primary antiphospholipid antibody syndrome

Canadian Journal of Ophthalmology

Volumn 47, Issue 6, 2012, Pages

  Turaka, Kiran ^a   Bryan, J Shepard ^a   Kwong Jr , Henry M ^a   Ziemianski, Matthew C ^a  

^a Associated Retina Consultants Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ENOXAPARIN; PREDNISOLONE; WARFARIN;

ADULT; ANTIPHOSPHOLIPID ANTIBODY SYNDROME; ANTIPHOSPHOLIPID SYNDROME; BILATERAL OCCLUSIVE RETINAL VASCULITIS; CASE REPORT; EYE EXAMINATION; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; LASER COAGULATION; LETTER; RETINA VASCULITIS; SLIT LAMP;

EID: 84884212039     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/j.jcjo.2012.07.010     Document Type: Letter

References (5)

1. Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol. 2002;47:215-38.
2. Utz VM, Tang J. Ocular manifestations of the antiphospholipid syndrome. Br J Ophthalmol. 2011;95:454-9.
3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
4. Kalogeropoulos CD, Spyrou P, Stefaniotou MI, et al. Anticardiolipin antibodies and occlusive vascular disease of the eye: Prospective study. Doc Ophthalmol. 1998;95:109-20.
5. Jeon S, Lee WK. Aggravated capillary non-perfusion after intravitreal bevacizumab for macular edema secondary to systemic lupus erythema-tosus and anti-phospholipid syndrome. Lupus. 2012;21:335-7.